"In order to produce a stockfeed additive one must appreciate that the additive is not a finished product, but simply a component of a finished product, which is the feed itself. If it is not manufactured with this in mind, it may be problematic in the feed in terms of quality, efficacy and safety".
D Pickard, Technical Director, Norfeed, UK, 1995
In the early 1980's the EEC proposed to ban Olaquindox and Carbadox considering the OH&S risks to handlers was simply too great. Dox-al scientists developed a novel approach to premixing which enabled these dangerous substances to comply with the new stringent EEC requirements of 0.1mg/M³ air as an occupational exposure limit (OEL). This unique internationally patented premixing technology has since been applied to an increasing number of feed additives known to be problematic in terms of OH&S, active recovery, stability during pelleting or extrusion, erratic dispersion within the feed mass or to control cross contamination of ingredients such as antibiotics, where sub therapeutic doses have been attributed to powdered or compacted granule medicated feed additive premixes.
Simply, the carrier microgranule, whose size, shape and robustness is designed to be incorporated into feed, is coated with the active principal and wrapped in a micronet of ionic character with surfactants covered under the patent. The resulting microgranule is practically dustless in all parts of the feed chain. It is neither hydrophile nor lipophile and has low resistivity. The benefits of the BMP® technology are now well understood and BMP® is the only feed additive technology approved by the European Union for application to an increasing number of feed additives where the active ingredients pose an OH&S risk. (EU Council Directive 80/1107/EEC).
BMP®
For a full CD presentation on Bi Modal Protection (BMP®) or product samples or literature, contact Dox-al Australia by selecting the link.